Bioniche Strengthens the International Patent Portfolio for its MCC Technology Platform
Bioniche Life Sciences Inc. announced the issuance of a number of patents in Japan for its proprietary Mycobacterial Cell Wall-DNA Complex (MCC) composition. These patents have claims related to broad MCC compositions, pharmaceutical compositions and medicament compositions. The Japanese pa ... > more